EGEN
Huntsville
About EGEN
EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $23.4M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2013)
- Website: egeninc.com
- Phone: 2565120077
Industries & Categories
Biotechnology, Health Care, Manufacturing, Therapeutics
Canonical: https://fsome.com/organization/egen-2232107 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.